domingo, 5 de julio de 2020

CD14: Diagnosing Early Risk of Dementia - Ivanhoe Broadcast News, Inc.

CD14: Diagnosing Early Risk of Dementia - Ivanhoe Broadcast News, Inc.

Marketing


HOUSTON, Texas (Ivanhoe Newswire) — Nearly 50 million people worldwide suffer from dementia, which affects their memory, language, and family relationships. Now, a blood marker called soluble CD14 is being studied as a potential tool in neurological disease.




SAN DIEGO, Calif. (Ivanhoe Newswire) — This year 140,000 people will die from a stroke. It happens when blood flow to the brain is blocked. A new procedure is opening up pathways and helping millions of people live longer, stroke-free, TCAR.




ORLANDO, Fla. (Ivanhoe Newswire) — From cancer to asthma, chronic inflammation is a culprit for many different diseases. Now, research is showing staying isolated, something most Americans are doing at some level right now, may cause Isolation-Causing-Inflammation?.




ORLANDO, Fla. (Ivanhoe Newswire) — Getting that dazzling white smile can cost big bucks. Each year, Americans spend more than a billion dollars on teeth whitening products. But there are cheaper and more natural alternatives. You can start with what you eat.




HOUSTON, Texas (Ivanhoe Newswire) — In the fight against aggressive prostate cancer, researchers are discovering that what’s old is new again. Cork tree bark, an herbal remedy that’s been around for centuries, is being studied as a way to shrink prostate tumors.






Doctor's In-depth Interview of the week
 
Saving Lungs Saving Lives 
Kristen Highland, MD, Director of The Rheumatic Lung Disease Program
The Cleveland Clinic



Quote of the week:

“Patriotism is supporting your country all the time, and your government when it deserves it.” 

— Mark Twain








If you know of an innovative medical treatment, send us the name of the treatment,  name of the doctor and city. We may be able to cover it in one of our series: newsalert@ivanhoe.com

Website Informationwebdoctor@ivanhoe.com

Content Licensing: jcherry@ivanhoe.com

No hay comentarios:

Publicar un comentario